233 related articles for article (PubMed ID: 30891426)
1. Hexosamine Biosynthetic Pathway and Glycosylation Regulate Cell Migration in Melanoma Cells.
de Queiroz RM; Oliveira IA; Piva B; Bouchuid Catão F; da Costa Rodrigues B; da Costa Pascoal A; Diaz BL; Todeschini AR; Caarls MB; Dias WB
Front Oncol; 2019; 9():116. PubMed ID: 30891426
[TBL] [Abstract][Full Text] [Related]
2. Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.
Lucena MC; Carvalho-Cruz P; Donadio JL; Oliveira IA; de Queiroz RM; Marinho-Carvalho MM; Sola-Penna M; de Paula IF; Gondim KC; McComb ME; Costello CE; Whelan SA; Todeschini AR; Dias WB
J Biol Chem; 2016 Jun; 291(25):12917-29. PubMed ID: 27129262
[TBL] [Abstract][Full Text] [Related]
3. First characterization of glucose flux through the hexosamine biosynthesis pathway (HBP) in
Olson AK; Bouchard B; Zhu WZ; Chatham JC; Des Rosiers C
J Biol Chem; 2020 Feb; 295(7):2018-2033. PubMed ID: 31915250
[TBL] [Abstract][Full Text] [Related]
4. Bittersweet tumor development and progression: Emerging roles of epithelial plasticity glycosylations.
Phillips RM; Lam C; Wang H; Tran PT
Adv Cancer Res; 2019; 142():23-62. PubMed ID: 30885363
[TBL] [Abstract][Full Text] [Related]
5. Cellular glycosylation senses metabolic changes and modulates cell plasticity during epithelial to mesenchymal transition.
Carvalho-Cruz P; Alisson-Silva F; Todeschini AR; Dias WB
Dev Dyn; 2018 Mar; 247(3):481-491. PubMed ID: 28722313
[TBL] [Abstract][Full Text] [Related]
6. O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle.
Hanover JA; Chen W; Bond MR
J Bioenerg Biomembr; 2018 Jun; 50(3):155-173. PubMed ID: 29594839
[TBL] [Abstract][Full Text] [Related]
7. The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring.
Chiaradonna F; Ricciardiello F; Palorini R
Cells; 2018 Jun; 7(6):. PubMed ID: 29865240
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of hexosamine biosynthetic pathway wiring metabolic signaling circuits in cancer.
Itano N; Iwamoto S
Biochim Biophys Acta Gen Subj; 2023 Jan; 1867(1):130250. PubMed ID: 36228878
[TBL] [Abstract][Full Text] [Related]
9. The Hexosamine Biosynthesis Pathway: Regulation and Function.
Paneque A; Fortus H; Zheng J; Werlen G; Jacinto E
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107691
[TBL] [Abstract][Full Text] [Related]
10. Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer.
Akella NM; Ciraku L; Reginato MJ
BMC Biol; 2019 Jul; 17(1):52. PubMed ID: 31272438
[TBL] [Abstract][Full Text] [Related]
11. Aberrant O-GlcNAcylated Proteins: New Perspectives in Breast and Colorectal Cancer.
Chaiyawat P; Netsirisawan P; Svasti J; Champattanachai V
Front Endocrinol (Lausanne); 2014; 5():193. PubMed ID: 25426101
[TBL] [Abstract][Full Text] [Related]
12. O-GlcNAcylation in Cancer Biology: Linking Metabolism and Signaling.
Ferrer CM; Sodi VL; Reginato MJ
J Mol Biol; 2016 Aug; 428(16):3282-3294. PubMed ID: 27343361
[TBL] [Abstract][Full Text] [Related]
13. GFAT1/HBP/O-GlcNAcylation Axis Regulates
Jia C; Li H; Fu D; Lan Y
Biomed Res Int; 2020; 2020():1921609. PubMed ID: 32149084
[TBL] [Abstract][Full Text] [Related]
14. The hexosamine biosynthetic pathway and cancer: Current knowledge and future therapeutic strategies.
Lam C; Low JY; Tran PT; Wang H
Cancer Lett; 2021 Apr; 503():11-18. PubMed ID: 33484754
[TBL] [Abstract][Full Text] [Related]
15. O-GlcNAc elevation through activation of the hexosamine biosynthetic pathway enhances cancer cell chemoresistance.
Liu Y; Cao Y; Pan X; Shi M; Wu Q; Huang T; Jiang H; Li W; Zhang J
Cell Death Dis; 2018 May; 9(5):485. PubMed ID: 29706631
[TBL] [Abstract][Full Text] [Related]
16. Anticancer Properties of Hexosamine Analogs Designed to Attenuate Metabolic Flux through the Hexosamine Biosynthetic Pathway.
Saeui CT; Shah SR; Fernandez-Gil BI; Zhang C; Agatemor C; Dammen-Brower K; Mathew MP; Buettner M; Gowda P; Khare P; Otamendi-Lopez A; Yang S; Zhang H; Le A; Quinoñes-Hinojosa A; Yarema KJ
ACS Chem Biol; 2023 Jan; 18(1):151-165. PubMed ID: 36626752
[TBL] [Abstract][Full Text] [Related]
17. Hijacking the Hexosamine Biosynthetic Pathway to Promote EMT-Mediated Neoplastic Phenotypes.
Taparra K; Tran PT; Zachara NE
Front Oncol; 2016; 6():85. PubMed ID: 27148477
[TBL] [Abstract][Full Text] [Related]
18. O-GlcNAcylation is required for mutant KRAS-induced lung tumorigenesis.
Taparra K; Wang H; Malek R; Lafargue A; Barbhuiya MA; Wang X; Simons BW; Ballew M; Nugent K; Groves J; Williams RD; Shiraishi T; Verdone J; Yildirir G; Henry R; Zhang B; Wong J; Wang KK; Nelkin BD; Pienta KJ; Felsher D; Zachara NE; Tran PT
J Clin Invest; 2018 Nov; 128(11):4924-4937. PubMed ID: 30130254
[TBL] [Abstract][Full Text] [Related]
19. Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer.
Vasconcelos-Dos-Santos A; Oliveira IA; Lucena MC; Mantuano NR; Whelan SA; Dias WB; Todeschini AR
Front Oncol; 2015; 5():138. PubMed ID: 26161361
[TBL] [Abstract][Full Text] [Related]
20. Targeting Protein
Bolanle IO; Palmer TM
Cells; 2022 Feb; 11(4):. PubMed ID: 35203353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
